To investigate whether single nucleotide polymorphisms (SNPs) in genes encoding the Toll-like receptor (TLR) signaling pathway modulate susceptibility to preterm birth (PTB). STUDY DESIGN: Prospective case-control study examining the contribution of nine TLR SNPs to PTB (o37 weeks) and PTB o32 weeks. Genotyping was done on neonatal blood using a multiplexed single-base extension assay. Chi-square test, Fischer's exact test and classification trees were used for data analysis. RESULT: Preterm infants (n ¼ 177) were more likely to be African American (P ¼ 0.02), and were more likely to be born to mothers who smoked (P ¼ 0.007), had pregnancy-induced hypertension (PIH; P ¼ 0.002) and placental abruption (P ¼ 0.0004) when compared with term infants (n ¼ 146). The TLR2, TLR4, TLR5, TLR9, nuclear factor-kappa B1 (NFkB1), NFkBIA and IRAK1 variants were not associated with PTB whereas the TIR domain receptor-associated protein (TIRAP) variant was more prevalent in term infants when compared with preterm infants born o32 weeks (P ¼ 0.004). PTB o32 weeks was more prevalent in infants without the TIRAP variant whose mothers had PIH and did not smoke (P ¼ 0.001). Presence of the TIRAP variant protected against PTB o32 weeks (P ¼ 0.015) in Caucasian infants. CONCLUSION: In our study, a TLR pathway adapter variant (TIRAP (rs8177374)) protected against PTBo32 weeks, supporting our hypothesis that genetic variation in the innate immune signaling pathway contributes to altered risk of PTB.
INTRODUCTION
Prematurity leads to significant morbidity and mortality in the neonatal period and has a reported prevalence of 12% in the USA, accounting for over half a million births each year. 1 Complications arising from premature birth remain the leading cause of death during infancy among African-American infants. Preterm birth (PTB) accounts for one in five children with mental retardation, one in three children with vision impairment and almost half of children with cerebral palsy. Over the last two decades, PTB rates have risen approximately 30%, reaching 12.7% in 2005. Although multiple factors contribute to the risk of PTB, there is increasing evidence that genetic factors have an important role in determining risk. 2 Maternal factors that have been associated with PTB risk include demographic characteristics, nutritional status, pregnancy history, psychological characteristics, infection, uterine contractions and cervical length, and biological and genetic markers. 3 Although the role of the fetus in initiating PTB is known, 4 ,5 the contribution of fetal genetic variation in modulating predisposition to prematurity remains understudied.
The presence of a fetal inflammatory response in addition to a maternal inflammatory response appears more strongly associated with extreme PTB (o29 weeks) than the presence of a maternal inflammatory response alone. 6 The mechanism by which intrauterine infection, a key event that has a central, causative role in PTB, 2, 7 leads to preterm labor is related to activation of the innate immune system. 8 Microorganisms are recognized by patternrecognition receptors such as Toll-like receptors (TLRs), which in turn elicit the release of inflammatory chemokines and cytokines-such as interleukin (IL), 8 IL-1b and tumor necrosis factor alpha (TNF-a). Microbial endotoxins and pro-inflammatory cytokines stimulate the production of prostaglandins, other inflammatory mediators and matrix-degrading enzymes. These factors in turn lead to uterine contractions and rupture of membranes, thus initiating PTB. Other investigators have demonstrated associations between cytokine genetic polymorphisms (high pro-inflammatory and low antiinflammatory cytokine producers) and the risk for PTB. 9, 10 TLRs are capable of recognizing microbial pathogens and activating the immune response before activation of the adaptive immune system. The mammalian family of TLRs number at least 10 distinct receptor proteins. 11, 12 Activation of TLR proteins triggers a complex signaling cascade, resulting in the activation of multiple transcription factors, for example, nuclear factor-kappa B (NF-kB) and activator protein 1 that induce the expression of pro-inflammatory cytokines, notably IL-1, IL-6 and TNF-a. At the maternal-fetal interface, TLRs are expressed not only in immune cells but also in non-immune cells such as trophoblasts and decidual cells. 13 Innate immune responses against microorganisms at the maternal-fetal interface may have a significant impact on the duration of pregnancy because intrauterine infections are strongly associated with premature labor. 13 We hypothesized that genetic variation in the fetal TLR signaling pathway genes will modulate susceptibility to PTB.
METHODS

Study design
This was a prospective cohort study with recruitment stratified by gestational age which was conducted at three centers ( 
Subjects
Prematurity was defined as birth before 37 weeks of gestation.
14 Clinical and demographic data were collected from hospital electronic medical records as well as patient charts, de-identified, and entered into preformatted data sheets and stored in a secure database.
Eligibility criteria
All infants born at Children's Hospital of Wisconsin or Waukesha Memorial Hospital and admitted to either the new-born nursery or the NICU were eligible for the study.
Exclusion criteria
All babies with congenital anomalies and who were products of a multiple pregnancy were excluded from the study. Infants born to mother with pregnancy-induced hypertension (PIH) were not excluded because of reports in the literature that immune mechanisms might contribute to PIH. 15 
Selection of SNPs
Candidate TLR genes that are critical for mediating immune responses against infectious agents were targeted. SNPs in these genes were identified from public databases (dbSNP, PUBMED) based on whether: (1) variants were previously reported to be associated with human infectious disease or PTBs, (2) variants were known to alter expression or function of the gene, and (3) had a mean allele frequency of 42% in the Caucasian population.
Laboratory methods
Genomic DNA was extracted from human neonatal blood samples (0.5 to 1 ml obtained from either umbilical cord at birth or by venipuncture or heel stick) using the FlexiGene DNA kit (Qiagen, Valencia, CA, USA) and stored at 4 1C. Nine TLR SNPs for eight loci (four TLR receptors, 2, 4, 5 and 9, two downstream signaling proteins, IRAK1 (interleukin-1 receptorassociated kinase 1) and NFkB1A, one adapter molecule, TIR domain receptor-associated protein (TIRAP), and one nuclear transcription factor, NFkB1) were analyzed and compared between cases and controls. We chose downstream molecules because some of them can be bottlenecks affecting downstream signaling through multiple TLRs. The SNPs which were investigated in this study are listed (Table 1) , with their accession numbers and functional annotations. A multiplexed single-base extension assay was developed for genotyping essentially as described by Koukouritaki et al. 16 except using the PRISM SNaPshot Multiplex kit (Applied Biosystems, Foster City, CA, USA). Individual single-base extended fragments were separated according to size and fluorescence detected using the ABI PRISM 3130xl Genetic Analyzer (Applied Biosystems). Output from experimental samples was compared with that obtained from reactions using cloned genomic templates representing the reference or variant alleles, or an equal mixture of both. Chromatogram results normalized with GeneScan-120 LIZ size standard (Applied Biosystems) were analyzed using ABI GeneScan software (Applied Biosystems).
Statistical analysis
The distribution of SNPs between the groups was analyzed using Chisquare, Fisher's exact and Cochrane Armitage trend tests. A power calculation was done for an a of 0.05, and we estimated that a sample size of 320 infants (150 term, 170 preterm) would provide 80% power to detect differences in the prevalence of TLR variant between cases and controls of 18 to 20% and an odds ratio of 2.5 to 3.6. We aimed to do a stratified analysis comparing term vs preterm infants o37-week gestation and also term vs preterm o32-week gestation as genetic risk factors might have a more important role in determining susceptibility to PTB at lower gestational ages. We therefore recruited 103 infants with gestational age o32 weeks and 470 preterm infants with gestational age 432 weeks too37 weeks. Classification and regression trees (SPSS version 20, Salford Systems CART Analysis, San Diego, CA) were used for interrelated effects of SNPs and demographic factors. We used a bootstrapping approach for the trees to ensure a stable tree. We also used biological and clinical considerations to prune the tree. Criteria used in the tree analysis were based on Gini method for classification (optimization function), with 20% of cases selected as test data (test set) and minimal terminal nodes ¼ 5 and maximum parent nodes ¼ 15 (when to stop splitting).
RESULTS
Population characteristics
We recruited 328 infants: 150 were term infants, 178 were preterm (o37 weeks) and among the preterm infants, 103 infants had a gestational age o32 weeks. Five infants (4 term and 1 preterm infant) were excluded from the study as genotyping was not possible because of DNA degradation. Baseline demographic and clinical characteristics of the two groups are described in Table 2 . The incidence of PIH (term vs preterm P ¼ 0.02; term vs pretermo32 weeks P ¼ 0.017), maternal smoking (term vs preterm P ¼ 0.007; term vs pretermo32 weeks P ¼ 0.003), placental abruption (term vs preterm P ¼ 0.0004; term vs pretermo32 weeks P ¼ 0.001) and a family history of premature delivery (term vs preterm P ¼ 0.006; term vs pretermo32 weeks P ¼ 0.016) were significantly higher in mothers who delivered preterm babies. The incidence of gestational diabetes was higher (P ¼ 0.005) in mothers who delivered term babies. There were no differences in the incidence of clinical chorioamnionitis, maternal drug use and distribution of gender between the three groups.
Association between TLR variants and prematurity Hardy-Weinberg equilibrium was confirmed for all loci. The results of genotyping for the nine TLR pathway SNPs is presented stratified by gestational age in Table 3 . Variant allele frequencies were not statistically different among term infants, preterm o37 weeks or preterm infants o32 weeks for the TLR2, TLR4, TLR5, TLR9, NFkB1, NFkBIA and IRAK1 SNPs. The TIRAP variant showed a trend towards increased prevalence in term infants (term vs pretermo37 weeks, P ¼ 0.06). On examining the distribution of the TIRAP variant across the three groups, we found the SNP prevalence was significantly lower only in infants born with gestational age o32 weeks (Figure 1 ). This was further confirmed by the Cochrane Armitage trend test (P ¼ 0.0016, term vs pretermo32 weeks). These data suggest a protective role for the TIRAP variant against PTB o32 weeks.
Classification and Regression Tree Analysis (CART) As the distribution of the TIRAP variant differed significantly between term infants and preterm infants born at o32 weeks, we did a CART analysis on 249 infants (excluding the late preterm group) to look for interrelated effects of SNPs and demographics. In this analysis, maternal smoking was a strong predictor of PTB. Among infants born to mothers who did not smoke, the presence of the TIRAP variant and absence of the NFkB1 variant were protective against PTB (Figure 2) . However, the effect of NFkB1 variant was not seen in a univariate analysis as was seen with the presence of the TIRAP variant. Analyzing the interaction of TIRAP variant and demographic variables, it was found that all mothers who smoked delivered preterm infants o32 weeks (Figure 2 ). Excluding infants born to mothers who smoked, PTB o32 weeks was significantly higher (Po0.001) among infants who did not have the TIRAP variant and were born to mothers who had PIH ( Table 4) .
Distribution of the TIRAP variant in the Caucasian population We then analyzed the effect of the TIRAP variant on PTB in Caucasian infants alone (the largest racial group). There were 121 term infants and 119 preterm infants o37 weeks gestation among whom 61 infants were born at o32 weeks. The number of infants who had the TIRAP variant was not significantly different between term infants (38/121 (31.4%)) and preterm infants o37 weeks (28/ 119 (23.5%)). However, the number of preterm infants o32 weeks who had the TIRAP variant (9/61 (14.7%)) was significantly lower (P ¼ 0.019, odds ratio 0.40, 95% CI; 0.16 to 0.9) than the number of term infants (38/121 (31.4%)) who had the TIRAP variant.
DISCUSSION
Although epidemiological studies clearly suggest that genetic factors contribute to the risk of PTB, the quest for identification of 3 or fetal heart rate of 4160/min). Comparisons were done between term infants vs the other two groups (preterm o37 weeks and preterm o32 weeks) using Chi-Square and Fisher Exact tests. Abbreviations: IRAK1, interleukin-1 receptor-associated kinase 1; NFkB, nuclear factor-kappa B; PTB, preterm birth; SNP, single nucleotide polymorphism; TIRAP, TIR domain receptor-associated protein; TLR, Toll-like receptor. *P value o0.004 (term vs preterm o32 weeks), **P value 0.08 (term vs preterm o32 weeks), ***P value 0.06 (term vs preterm o37 weeks). Allelic frequencies of study subjects according to outcome (term vs preterm o37 weeks vs preterm o32 weeks) are presented. Chi-Square or Fisher exact tests were used for comparisons between the groups and for generating P-values.
genetic biomarkers that can predict PTB reliably is ongoing. Our study supports the hypothesis that fetal genetic variation in the innate immune signaling pathway modulates susceptibility to PTB by altering host inflammatory responses to microbes at the maternal-fetal interface. The major finding in this study is that a TLR pathway adapter variant (TIRAP rs8177314) protects against the risk of PTB o32 weeks. Although we report some novel data on the genetics of PTB, the use of a genetically heterogenous population and the lack of a replication cohort remain limitations of this study. TLRs belong to a family of pattern-recognition receptors that mediate specific innate immune responses upon recognition of conserved structural motifs in bacteria, viruses and fungi. TLRs are widely expressed at the maternal-fetal interface, not only by immune cells (like Hofbauer cells) but also by non-immune cells such as trophoblasts and decidual cells. 13 Alterations in the innate immune response against microorganisms at the maternal-fetal interface may have a significant impact on the success of pregnancy because intrauterine infections have been shown to be strongly associated with PTB. 13, 17 In a Finnish study, there was no significant association between TLR4 polymorphisms (rs4986790) and premature birth. 18 Our study concurs with the findings of the Finnish study. Krediet et al. 19 found a significantly higher frequency of the TLR2 (rs5743708) polymorphism in premature neonates of o30 weeks gestation, which was not replicated in our study. Krediet and colleagues' study population was predominantly Caucasian and they excluded babies whose mothers had pre-eclampsia. Our population distribution is more genetically heterogenous and we included babies whose mothers had pre-eclampsia because studies have shown that maternal PIH itself represents an altered inflammatory state and that TLR4 and NOD2 gene variants are associated with maternal PIH and pre-eclampsia. 15, 20 Another explanation for the difference between the two studies could be that the current study was underpowered to detect differences in a low-frequency variant like TLR2. Finally, environmental factors that could interact with the TLR2 variant to confer increased PTB risk were not evaluated.
Our study is unique in that we examined not only the TLR SNPs but also some of the downstream mediators like TIRAP. TIRAP, also known as MAL (Myd88 adaptor-like protein), is involved in the MyD88-dependent downstream signaling of TLR2 and TLR4. 21, 22 Upon activation of TLR2 or TLR4, a signaling cascade is initiated, which leads to activation of transcription factors such as NFkB and activator protein 1, ultimately culminating in the production of pro-inflammatory cytokines. 23, 24 Previous studies have shown that the TIRAP variant ( rs8177314) confers protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis in adults. This TIRAP variant impairs downstream signaling by first inhibiting IKBa, which in turn leads to inhibition of NFkB activation. 25 Khor et al. 25 reported that the TIRAP variant encoding a Ser180Leu amino-acid change abrogates TLR2-dependent inflammatory responses in murine embryonic fibroblasts. We speculate that the TIRAP variant investigated in this study confers protection against premature birth by similarly decreasing downstream cytokine expression in response to bacterial ligands at the maternal-fetal interface. Our study is the first to demonstrate a possible protective effect of a TLR signaling pathway variant on the risk of prematurity. We then examined interactions between The race coding of white vs others was the best fit. Under such a coding, we found that NFkB1 (nuclear factor-kappa B1) and TIR domain receptor-associated protein (TIRAP) appear under the No smoking group and the receiver operating characteristic ¼ 0.71 is relatively good. TIRAP variant and demographic variables such as maternal smoking and PIH that alter susceptibility to PTB. 20, 26 In our cohort, we found that all mothers who smoked delivered a preterm baby o32 weeks confirming data reported previously. 26 PTB o32 weeks was more prevalent in infants who did not have the TIRAP variant but their mothers had PIH. This supports the fact that PTB is multi-factorial and genetic factors that protect or increase susceptibility to PTB are altered by other risk factors like PIH, which increase PTB.
Experimental animal data as well as human studies strongly suggest a role for pro-inflammatory responses in inducing preterm labor, whereas anti-inflammatory cytokine responses appear to be beneficial for the maintenance of pregnancy. 27 Other investigators have examined the relationships between cytokine gene polymorphisms and susceptibility to prematurity. Engel et al. 9 showed that selected TNF-a haplotypes were associated with spontaneous PTB, whereas Simhan et al. 28 showed that women who carry the IL-6-174 C/C variant are less likely to have PTB. We decided to examine SNPs in the TLR signaling pathway because they regulate expression of cytokines in response to bacteria. However, our data are consistent with other studies in that they demonstrate a role for genetic variants in the immune/inflammatory pathways in modulating the risk of PTB.
Many studies have highlighted the importance of geneenvironment interactions in contributing to PTB risk. Bacterial vaginosis, known to induce PTB, also is reported to be associated with TLR4 polymorphisms. 29 This aspect was not examined in our study. Simhan et al. 30 in their prospective observational cohort study of 109 women found that maternal (rs10759932) and fetal (rs1554973) genetic variation in TLR4 demonstrated highly significant independent association with chorionic plate inflammation. We did not do maternal genotyping and, moreover, we examined different infant TLR4 SNPs (rs4986790 and rs4986791), and our criterion for chorioamnionitis was clinical rather than histological. We plan to look at a possible association between the TIRAP variant and histological chorioamnionitis in the future. Our study looked at the interaction of maternal smoking, which is an important and well-known cause of PTB, and infant genetic polymorphisms on PTB. The CART analysis found that mothers who did not smoke during pregnancy were more likely to deliver term babies if their infants had the variant allele for TIRAP and lacked the NFkB1 variant. Further, although our population was heterogeneous, the protective effect of the TIRAP variant against PTB o32 weeks persisted in Caucasian infants.
In conclusion, our study shows that the TIRAP (rs8177374) variant protected against PTB o32 weeks, supporting our hypothesis that fetal TLR sequence variation contributes to altered PTB risk. Because the TLR pathway regulates inflammatory responses to bacteria and increased inflammation at the maternal-fetal interface is associated with PTB, it is biologically plausible that the TIRAP variant by suppressing TLR2/TLR4-mediated responses can protect against PTB. Future studies will focus on investigating the influence of maternal/infant genotype on placental inflammation and prematurity o32 weeks with the aim of developing algorithms to predict risk of PTB based on parental genotype.
